AI Article Synopsis

  • There is an increasing interest in using capillary blood sampling to measure drugs, specifically phosphatidylethanol (PEth) as a biomarker for alcohol intake.
  • The study aimed to adapt an existing method for quantifying PEth in venous blood to also work with dried blood spots collected using two different volumetric absorptive microsampling devices, Capitainer®B and Mitra®.
  • The Mitra device met all validation criteria for PEth measurement, while the Capitainer device had a slight accuracy issue for higher PEth levels, but overall both devices were deemed suitable for analyzing PEth in capillary blood.

Article Abstract

There is a growing interest for quantification of drugs in capillary blood. Phosphatidylethanol (PEth) is a biomarker for alcohol intake measured in whole blood, thus making it a candidate for capillary sampling. Our laboratory has been running a method for PEth quantification in venous blood since 2016 and we aimed to expand this method to also include capillary dried blood spot (DBS) samples. Two 10 µL volumetric absorptive microsampling (VAMS) devices, Capitainer®B Vanadate and Mitra® were included in the method development and validated. Calibrators and quality controls were spiked during the automatic sample extraction without the VAMS devices present, making it possible to extract and analyze both types of VAMS samples in the same set-up. With the Mitra device all pre-established validation criteria were fulfilled in the measuring range 0.03-4.0 µM (21-2812 ng/mL), including method comparison with our venous blood method. Capitainer fulfilled all validation criteria, except for the accuracy of samples with PEth levels ≥ 0.5 µM (≥ 352 ng/mL) (deviation -17.1 to -20.5%). The correlation analysis between Capitainer and the venous blood results showed no constant bias, but an acceptable small proportional mean difference of -7.6%. Overall, the method validation results for both Capitainer and Mitra were considered acceptable. Both devices were found suitable for the analyses of PEth.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jat/bkaf004DOI Listing

Publication Analysis

Top Keywords

vams devices
12
venous blood
12
phosphatidylethanol peth
8
µl volumetric
8
volumetric absorptive
8
validation criteria
8
blood
6
method
6
peth
5
validated method
4

Similar Publications

Article Synopsis
  • There is an increasing interest in using capillary blood sampling to measure drugs, specifically phosphatidylethanol (PEth) as a biomarker for alcohol intake.
  • The study aimed to adapt an existing method for quantifying PEth in venous blood to also work with dried blood spots collected using two different volumetric absorptive microsampling devices, Capitainer®B and Mitra®.
  • The Mitra device met all validation criteria for PEth measurement, while the Capitainer device had a slight accuracy issue for higher PEth levels, but overall both devices were deemed suitable for analyzing PEth in capillary blood.
View Article and Find Full Text PDF

Blood microsampling (BμS) has recently emerged as an interesting approach in the analysis of endogenous metabolites but also in metabolomics applications. Their non-invasive way of use and the simplified logistics that they offer renders these technologies highly attractive in large-scale studies, especially the novel quantitative microsampling approaches such as VAMs or qDBS. Herein, we investigate the potential of BµS devices compared to the conventional plasma samples used in global untargeted mass spectrometry-based metabolomics of blood.

View Article and Find Full Text PDF

Development and validation of a quantification method for direct oral anticoagulants from capillary blood using volumetric absorptive microsampling and online SPE-LC-MS.

J Chromatogr B Analyt Technol Biomed Life Sci

January 2025

Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, Muenster, Germany. Electronic address:

The number of prescriptions for new direct oral anticoagulants (DOACs) apixaban, edoxaban, rivaroxaban and dabigatran has increased exponentially in recent years, increasingly replacing the old gold standard, vitamin-K-antagonists. Due to their wide therapeutic range, therapeutic drug monitoring (TDM) is not required, although it has been proven that this could significantly reduce side effects. In order to develop a cost-efficient and simple method for the simultaneous detection of the DOACs and phenprocoumon, a new technology for sample preparation from capillary blood in the ambulant sector named VAMS® was integrated and an LC-MS detector with on-line solid phase extraction (SPE) applying a Turboflow HTLC Cyclone 1.

View Article and Find Full Text PDF

Volumetric absorptive microsampling meets electromembrane extraction for the first time: Case example of doxorubicin and its metabolite in whole blood samples.

Anal Chim Acta

January 2025

Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03, Hradec Králové, Czech Republic. Electronic address:

Background: Microsampling of biological fluids followed by innovative sample pre-treatment reflects trends in bioanalytical chemistry. Volumetric absorptive microsampling (VAMS) enables exact whole blood volume collection and reduces the impact of hematocrit on the assay. In animal studies, it complies with the 3R principles (refine, reduce, replace).

View Article and Find Full Text PDF

Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS.

Anal Bioanal Chem

January 2025

Laboratoire de Toxicologie, Fédération de Toxicologie, Hôpital Lariboisière AP-HP, 2 Rue Ambroise Paré, 75010, Paris, France.

Article Synopsis
  • The increasing legalization of cannabis worldwide has led to a growing need for methods to accurately identify and quantify cannabis consumption, especially through non-invasive means.
  • Oral fluid, as an alternative to traditional blood and urine tests, offers advantages such as easier self-sampling and reduced risk of tampering, although it typically requires larger volumes to test effectively.
  • The study presents a new method that allows for the quantification of seven cannabinoids from just 20 µL of oral fluid using a specialized sampling device and advanced chemical techniques, achieving precise detection limits suitable for legal and clinical contexts.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!